Mizuho Securities Maintains Alkermes(ALKS.US) With Buy Rating
BofA Securities Maintains Alkermes(ALKS.US) With Hold Rating
Bank of America Securities Keeps Their Hold Rating on Alkermes (ALKS)
Mizuho Securities Maintains Alkermes(ALKS.US) With Buy Rating, Announces Target Price $40
Alkermes Is Maintained at Outperform by Mizuho
Alkermes Analyst Ratings
TD Cowen Maintains Alkermes(ALKS.US) With Buy Rating, Maintains Target Price $35
Stifel Maintains Alkermes(ALKS.US) With Buy Rating, Maintains Target Price $36
Alkermes Analyst Ratings
Stifel Upgrades Alkermes(ALKS.US) to Buy Rating, Raises Target Price to $36
Alkermes Inc.: Strong Q3 Performance and Strategic Growth Drive Buy Rating
Alkermes (ALKS) Gets a Hold From J.P. Morgan
Alkermes Is Maintained at Neutral by JP Morgan
Alkermes: Balancing Near-Term Challenges With Long-Term Orexin Market Potential Justifies Hold Rating
Cantor Fitzgerald Maintains Alkermes(ALKS.US) With Buy Rating, Cuts Target Price to $43
H.C. Wainwright Maintains Alkermes(ALKS.US) With Hold Rating, Maintains Target Price $37
BofA Securities Maintains Alkermes(ALKS.US) With Hold Rating
A Quick Look at Today's Ratings for Alkermes(ALKS.US), With a Forecast Between $30 to $43
Alkermes (ALKS) Receives a New Rating From Cantor Fitzgerald
Alkermes Analyst Ratings